Grupo 5: Cardiología y Trasplante Cardiaco Infantil
Código de grupo: 2.05
Tipo de grupo: Emergente
Descripción del grupo: Cardiología y trasplante cardiaco infantil
Jefe de Grupo: Constancio Medrano López
- Este grupo ha integrado recientemente a los investigadores del Grupo 7.23 Endocrinología pediátrica. Enfermedades hereditarias que desaparece como tal.
Integrantes del grupo | |
---|---|
Investigadores y personal de apoyo |
ALCAIDE | BAZÁN | PAOLA | First Stage Researcher |
ALCARAZ | MARIA TERESA | ||
ALONSO | PATRICIA | ||
ALVAREZ | GARCIA-ROVES | REYES | |
ALVAREZ | MARTIN | TERESA | |
ARRIBA | DOMENECH | MARÍA | Recognised Researcher |
BALLESTEROS | TEJERIZO | FERNANDO | First Stage Researcher |
CALLE | VALDA | ALTA CORAZÓN MABEL | |
CAMBRA | CONEJERO | ANA | |
CAMINO | LÓPEZ | MANUELA | |
CAMUÑA |
JOSE |
||
CARCHENILLA | PULIDO | INMACULADA | |
CENTENO | JIMÉNEZ | MIRIAN | |
COBOS | HINOJAL | SUSANA | |
CUENCA | YUNTA | ALEJANDRA | |
DE CASTRO | PILAR | ||
DIAZ | CESAR | MARIA | |
DOMARCO | MANRIQUE | ALEJANDRO | |
EZQUIETA | ZUBICARAY | BEGOÑA | Established Researcher |
FERRER | SANCHEZ | SOLEDAD | |
GARCIA | GONZALEZ | MARIA DOLORES | Support Technician |
GIL | JAURENA | JUAN MIGUEL | First Stage Researcher |
GIL | VILLANUEVA | NURIA | First Stage Researcher |
LOPEZ | BLAZQUEZ | MARIA | First Stage Researcher |
MARTIN | MAYORAL | ANABEL | First Stage Researcher |
MEDRANO | LOPEZ | CONSTANCIO | Leading Researcher |
MUÑOZ-PACHECO | ROMÁN | RAFAEL | |
PANADERO | CARLAVILLA | MARIA ESTHER | |
PARDO | PARDO | CARLOS ANDRES | |
PEREZ-CABALLERO | MARTINEZ | RAMON | |
PINERO | DIAZ | GLORIA ISABEL | |
PITA | FERNANDEZ | ANA | |
RELAÑO | GARCÍA | CRISTINA | |
RODRIGUEZ | OGANDO | ALEJANDRO | |
SOBRINO | BALADRON | ADOLFO | |
SOLANA | GRACIA | RUTH | |
ZUNZUNEGUI | MARTINEZ | JOSÉ LUIS | First Stage Researcher |
Líneas de investigación |
---|
Axis 1: Cardiac transplantation in children
L 1: Optimising and reducing anti-rejection therapies Axis 2: Myocardiopathy in infancy L 1: Genotype-phenotype correlation L 2: Development of advanced imaging techniques (speckel tracking echocardiography) Axis 3: Respiratory infections and congenital heart disease L1: Impact on heart disease population Axis 4: Drugs in paediatric paediatric cardiology L1: Utility and safety of cardiovascular drugs in childhood Axis 5: Paediatric cardiac rehabilitation (collaboration with Children’s Rehabilitation) L1: Improving quality of life Axis 6: Cell therapy in paediatric cardiology L1: New therapies in advanced heart failure Axis 7: Innovation in paediatric and congenital interventional cardiology congenital cardiac interventionism L1: New devices adapted to congenital heart disease Axis 8: Innovation in paediatric and congenital cardiac surgery L1: New mini-invasive techniques are safe, decrease morbidity Axis 9: Telemedicine L1: Tool to optimise the follow-up of patients and collaboration with other centres/professionals Axis 10: Rasopathies (in collaboration with Molecular Biochemistry: Dra. Begoña Ezquieta)”. L1: Improving knowledge of the disease Axis 11: International Cooperation L1: Training as a tool for development Axis 12: Innovation in Infant Electrophysiology L1: Optimising paediatric electrophysiological techniques and devices Axis 13: Paediatric cardiology care. L1: Optimising access to peripheral pathways L2: Music therapy |
First decile publications | 1 | 24,0 |
First quartile publications | 11 | 83,5 |
Second quartile publications | 0 | 0,0 |
Third quartile publications | 2 | 3,7 |
Total publications (including those without IF) | 24 | 90,5 |